Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8229914 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 8 Pages |
Abstract
Fractionated stereotactic radiotherapy results in excellent tumor control of AN, albeit with a risk of developing hydrocephalus. Patients at high risk, identified as those with larger tumors with partial effacement of the fourth ventricle before treatment, should be monitored more closely during follow-up. It would also be preferable to offer treatment to patients with progressive AN while the risk of hydrocephalus is low, before the development of marked distortion of fourth ventricle before tumor diameter significantly exceeds 2 cm.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ceri F.R.C.R., Caroline F.R.C.R., Adam B.Sc. (Hons.), Bev B.A. (Hons.), Sue Ph.D., Michael F.R.C.R., F.R.C.P.,